Descriptive Studies
Dr. Nadim Mahmud
Study Design · Research CurriculumCase reports and case series are the most accessible entry point for trainee researchers. This module explains when a case is worth writing up, how to structure a case report according to CARE guidelines, and how to avoid the most common mistakes that lead to rejection.
Introduction
Before the randomized trial, before the cohort study, before the hypothesis - there is the case. Clinical observation has driven some of the most important discoveries in medicine. The association between thalidomide and limb defects, the link between DES exposure and vaginal adenocarcinoma, the first cases of what would become the AIDS epidemic - all were identified through careful clinical description, not controlled experiments.
Descriptive studies sit at the base of the evidence hierarchy, but this does not make them unimportant. They are hypothesis-generating by design. A well-written case report identifies a pattern or association that others may not have noticed and invites the scientific community to investigate further.
Overview of Research Study Designs
Descriptive studies occupy a distinct position in the research design landscape. Unlike analytic studies - which test specific hypotheses about exposure-outcome relationships - descriptive studies characterize what is happening in a patient or group of patients. They do not have a comparison group and do not test statistical associations. Click "Show details" in the Descriptive branch to learn more.
Click "Show details" to learn more about the Descriptive branch
Case Reports
A case report is a detailed description of a single patient with a clinical presentation, diagnosis, management, or outcome that is novel, unusual, or particularly instructive. The defining features are: one patient, detailed description, and a clearly articulated educational point.
When is a case report publishable?
Not every interesting case is a publishable case report. The most important question is: What will the reader learn from this case that they could not have learned elsewhere? Cases that are worth publishing typically meet one or more of the following criteria:
First or rare description of a drug reaction, complication, or disease association not previously reported
Unusual presentation of a known disease that led to delayed or missed diagnosis - with lessons for clinicians
A patient who responded dramatically (positively or negatively) to a treatment in a way that was not predicted
A detailed description of a rare or emerging disease that adds to a limited literature base
A case that illustrates a high-yield clinical principle or pathophysiological concept in a particularly clear way
A case that raises a safety concern that may not yet be recognized in the broader clinical community
- 1961: A letter in The Lancet described 3 infants with rare limb malformations in West Germany - one of the first published signals of thalidomide teratogenicity. Within months, the drug was withdrawn globally.
- 1981: The first reports of Pneumocystis pneumonia in previously healthy young gay men in MMWR were essentially a case series - and constituted the first clinical description of AIDS.
- 1971: A landmark case series in NEJM described 7 young women with a rare vaginal adenocarcinoma and traced the common exposure: DES taken by their mothers during pregnancy.
Case Series
A case series describes a group of patients who share a common diagnosis, exposure, procedure, or clinical course. Unlike a cohort study, there is no comparison group. The goal is to characterize a pattern across multiple cases rather than test a specific hypothesis.
- Multiple patients with the same unusual presentation or complication
- A cluster of cases suggesting an emerging disease or outbreak
- Multiple patients treated with a novel approach with consistent outcomes
- When a single case would not be compelling but several cases together create a convincing pattern
The distinction lies in the control group. A case series has none. A retrospective cohort study compares exposed and unexposed patients. If you find yourself with a group of exposed patients and a way to identify unexposed comparators, consider whether a cohort study is feasible.
Even without a control group, a well-characterized case series can be a powerful publication - particularly for rare conditions where a control group is practically impossible.
Is My Case Worth Writing Up?
Use the tool below to assess whether your case has the key features that journals look for in a publishable case report. Answer each question to get an assessment.
Is the diagnosis rare (fewer than 1 in 100,000) or the presentation highly atypical?
Is there a clear, generalizable clinical lesson for the reader?
Does the case describe a previously unreported drug reaction, diagnosis, or treatment response?
Was the outcome unexpected (dramatic recovery, unexpected death, or unusual complication)?
Can you obtain informed consent from the patient (or next of kin)?
Did you perform a literature search confirming this case adds something new?
CARE Guidelines Checklist
The CARE (CAse REport) guidelines are the internationally accepted reporting standard for case reports. Published in 2013 and updated in 2017, they provide a 13-item checklist designed to ensure case reports contain the information necessary for readers to evaluate the case, replicate the approach, and learn from the experience.
Most journals that publish case reports now require adherence to CARE guidelines. Use the interactive checklist below to track your manuscript's progress.
Writing a Strong Case Report
Structure and clarity are everything in a case report. Reviewers read dozens of submissions. The ones that get accepted are the ones where the clinical message is immediately clear, the description is complete, and the discussion is grounded in the literature.
The introduction: set the context
The introduction should be brief (2-3 short paragraphs) and do three things: describe what is known about the condition, explain what is unusual or novel about this case, and state why it matters to the reader. Resist the temptation to write a mini-review of the disease. Save the synthesis for the discussion.
The case presentation: tell the clinical story
Write the case as a narrative. A clinician should be able to read it and feel like they are following the case in real time. Organize chronologically. Include relevant positives and pertinent negatives. Justify diagnostic and management decisions. A timeline figure or table is strongly recommended for complex cases.
The discussion: contextualize and teach
The discussion is where you earn the publication. It should be organized around the educational message, not a chronological retelling of the case. Start with a synthesis of what is known (from your literature search), then explain how your case adds to or deviates from prior reports. Address limitations honestly. End with a concise take-home message.
Choosing the right journal
Target specialty journals in your field first. Many major journals (NEJM, JAMA) accept case reports only rarely, and usually only for cases of exceptional novelty. Specialty journals (hepatology, cardiology, infectious disease) are often better venues for condition-specific cases. Dedicated case report journals (BMJ Case Reports, American Journal of Case Reports) have higher acceptance rates and are appropriate for well-written cases with good educational value even if not groundbreaking.
Limitations and Common Mistakes
Case reports have inherent limitations that stem from their design. Awareness of these limitations - and honesty about them in your manuscript - is a sign of methodological maturity.
A case report cannot prove that an exposure caused an outcome. It can suggest a temporal association and generate a hypothesis. Causality requires controlled study designs. This is a structural limitation, not a flaw - but your discussion must acknowledge it.
Dramatic cases - dramatic recoveries, dramatic complications, dramatic rarities - are far more likely to be written up and accepted than ordinary ones. This means the case report literature systematically overrepresents unusual outcomes. Be cautious about drawing generalizations from a single case or even a series of published cases.
Patients often seek care at their sickest and improve with time regardless of treatment. A patient who received an experimental treatment and recovered dramatically may simply have improved because of the natural disease course. This is a particularly important limitation when reporting treatment responses.
Even with names, dates, and identifying information removed, patients can often identify themselves (and be identified by others) from clinical details. Unique presentations, rare diseases, or specific geographic or demographic details can be identifying. The solution is not just technical de-identification - it is patient consent.
The most common reason for case report rejection. A single case cannot support a recommendation for clinical practice. The appropriate conclusion is that a pattern was observed and warrants further study, not that a drug should be adopted or avoided based on one patient.
Interactive Quiz
Test your understanding of descriptive study design, case report criteria, and reporting standards with these clinical scenarios.
A resident presents at morning report about a 58-year-old man who developed bilateral leg weakness three weeks after a mild COVID-19 illness. Nerve conduction studies confirmed Guillain-Barre syndrome. The patient recovered fully after IVIG. The team wonders if this should be written up.
A hepatologist notices that 6 of her patients with autoimmune hepatitis developed a new-onset inflammatory bowel disease within 12 months of starting azathioprine. She has detailed records for all 6 patients, including labs, pathology, and follow-up data. There is no comparison group.
A trainee asks whether patient consent is needed to submit a case report about a 34-year-old woman who presented with an unusual rash. The trainee argues that the case is de-identified (no name, date of birth changed, hospital name removed) and therefore consent is unnecessary.
A case report is submitted describing a patient who responded dramatically to a novel off-label use of a medication. The discussion concludes: 'Based on this case, we recommend that clinicians consider this drug for all patients with this condition.' A reviewer flags this conclusion.
Continue Learning
With the three major study design categories covered, the logical next steps are understanding how to conduct a systematic literature review to contextualize your case, and how to write up your findings for publication.
As your case generates hypotheses, cohort and case-control designs are how you test them.
Explore →Every case report requires a thorough literature review. Learn how to search systematically and synthesize what is known.
Explore →